The well-known factors that contribute to the development of dementia include genetics, age, lifestyle and even environment. But more and more research is pointing…
Biogen has agreed to buy an experimental Alzheimer’s and Parkinson’s treatment from Pfizer, the company announced Monday. In the agreed deal, Biogen will pay…
While researchers are looking into new forms of medicinal solutions to dementia, more and more attention is being paid to lifestyle-focused approaches to the…
Being Patient spoke with Kaitlin Casaletto, a neuropsychologist and assistant professor at UCSF Memory and Aging Center, about the results of her study on…
Pulling an all-nighter or getting fewer hours of sleep than normal may have more consequences than simply suffering fatigue during the work day. According…
Scientists are continuing to search for answers to Alzheimer’s disease and other dementias, targeting beta-amyloid and tau protein, inflammation, and genetic factors in research…
When it comes to Alzheimer’s, what happens first: beta amyloid plaques, or the visible personality and cognitive changes common with the disease? Researchers have…
If you needed more motivation to get moving in the new year, a new study provides more evidence that exercise can help keep your…
Much of Alzheimer’s research has focused on beta-amyloid plaques, one of the main drivers behind neurodegeneration in people with dementia. But more and more…
Chinese officials announced conditional approval to a seaweed-based drug in November. Now, it’s available on the Chinese market. Oligomannate is the first drug to…
The exact causes behind dementia are varied and at times unclear. We know that genetic factors — like carrying the APOE4 gene — can…
Having conversations about end of life care is difficult at any age, but for seniors, it can be especially difficult. Facing your mortality is…
“My mom died peacefully this afternoon after a decade-long battle with Alzheimer’s and dementia,” professional skateboarder Tony Hawk, 51, wrote on his Facebook page…
As research into a cure — or at least treatment — for Alzheimer’s continues, scientists are looking beyond the pathways of targeting tau or…
Biogen announced this week that it was cancelling the dementia drug it was testing in a Phase 2 trial that aimed to fight tau…